Cerebral Vasospasm Companies

ID: MRFR/MED/0909-HCR

85 Pages

Kinjoll Dey

September 2025

Cerebral vasospasm is a condition characterized by the narrowing of blood vessels in the brain, often occurring after a subarachnoid hemorrhage (SAH), which is bleeding into the space surrounding the brain. This narrowing can lead to reduced blood flow to the brain, resulting in potentially serious complications such as ischemic stroke. Various companies are involved in the research, development, and commercialization of products and therapies aimed at addressing cerebral vasospasm.

Cerebral Vasospasm Market Research Report- Forecast to 2032 Infographic

Summary Table of Contents Segmentation Infographic

Top Industry Leaders in the Cerebral Vasospasm Market

Cerebral Vasospasm Key Companies

Latest Cerebral Vasospasm Companies Update

Headsense Medical Developed a novel external cooling device aiming to prevent vasospasm by lowering brain temperature. The device remains in clinical trials.

Bristol-Myers Squibb Company Continued research on nimodipine, a calcium channel blocker with limited efficacy in preventing vasospasm but still utilized in clinical practice.

Other players Smaller companies and research institutions are actively investigating new drugs and treatment modalities, but major breakthrough news is lacking at the moment.

List of Cerebral Vasospasm Key Companies in the Market

Headsense Medical Ltd.,

Braun Melsungen,

Minnetronix,

Bristol-Myers Squibb Company,

Ingehlium GmbH,

Lundbeck A/S,

Actellion Pharmaceuticals Ltd.,

GE Healthcare,

Edge Therapeutics Inc.,

Siemens AG,

Aritria Medical,

Philips N.V.